التفاصيل البيبلوغرافية
| العنوان: |
Assessment of Cardiovascular Disease Risk and Therapeutic Patterns among Urban Black Rheumatoid Arthritis Patients. |
| المؤلفون: |
McFarlane, Isabel M., Leon, Su Yien Zhaz, Bhamra, Manjeet S., Burza, Aaliya, Waite, Stephen Anthony, Rodriguez Alvarez, Milena, Koci, Kristaq, Taklalsingh, Nicholas, Kaplan, Ian, Pathiparampil, Joshy, Kabani, Naureen, Watler, Elsie, Sorrento, Cristina S., Frefer, Mosab, Vaitkus, Vytas, Green, Jason, Matthew, Keron, Arroyo-Mercado, Fray, Lyo, Helen, Soliman, Faisal |
| المصدر: |
Medical Sciences; Feb2019, Vol. 7 Issue 2, p31, 1p |
| مصطلحات موضوعية: |
DYSLIPIDEMIA, RHEUMATOID arthritis, THERAPEUTIC complications, CARDIOVASCULAR diseases, BLACK people, BODY mass index |
| مستخلص: |
Rheumatoid arthritis (RA) patients have nearly twice the risk of cardiovascular disease (CVD) compared to the general population. We aimed to assess, in a predominantly Black population, the prevalence of traditional and RA-specific CVD risk factors and therapeutic patterns. Utilizing ICD codes, we identified 503 RA patients ≥18 years old who were seen from 2010 to 2017. Of them, 88.5% were Black, 87.9% were women and 29.4% were smokers. CVD risk factors (obesity, diabetes, hypertension, dyslipidemia) were higher than in previously reported White RA cohorts. Eighty-seven percent of the patients had at least one traditional CVD risk factor, 37% had three or more traditional CVD risk factors and 58% had RA-specific risk factors (seropositive RA, >10 years of disease, joint erosions, elevated inflammatory markers, extra-articular disease, body mass index (BMI) < 20). CV outcomes (coronary artery disease/myocardial infarction, heart failure, atrial fibrillation and stroke) were comparable to published reports. Higher steroid use, which increases CVD risk, and lesser utilization of biologics (decrease CV risk) were also observed. Our Black RA cohort had higher rates of traditional CVD risk factors, in addition to chronic inflammation from aggressive RA, which places our patients at a higher risk for CVD outcomes, calling for revised risk stratification strategies and effective interventions to address comorbidities in this vulnerable population. [ABSTRACT FROM AUTHOR] |
|
Copyright of Medical Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder